Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

An open-label study of botulinum toxin A for treatment of tardive dystonia.

An open-label study of botulinum toxin A for treatment of tardive dystonia. Clin Neuropharmacol. 1997 Feb; 20(1):90-3.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.